Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins

Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins

US Patent 6730664 · Granted May 4, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Powder composition based on microparticles embedding nanoparticles for the deliv2025
Method for the preparation of friction material, specifically for the manufactur2024
Production of glass bodies from polymerisable solutions2024
Geopolymeric formulations and associated methods for the manufacturing of three-2023
Salt of cysteamine for the preparation of highly respirable particles2023
Seamless, and/or graded transition from sintered alternative-binders-based imper2022
Geopolymeric formulations and associated methods for the manufacturing of three-2021
Crystalline microparticles of a beta-agonist coated with a fatty acid2021
Friction material, in particular for the manufacturing of a brake pad, and assoc2021
Formulations of cysteamine and cysteamine derivatives2020
Porous glass ceramic composition and method for manufacturing the same2019
Friction material, in particular for the manufacturing of a brake pad, and assoc2018